Greenfield, IN, United States of America

Jack F Wagner

This inventor holds 3 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1980-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 1.5

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 1980-1991

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jack F Wagner: Innovator in Growth Hormone Treatments

Introduction

Jack F Wagner is a notable inventor based in Greenfield, IN (US). He has made significant contributions to the field of veterinary medicine and animal husbandry. With a total of 3 patents, his work focuses on enhancing the health and productivity of economic mammals through innovative treatment methods.

Latest Patents

Wagner's latest patents include a synergistic treatment method that increases the concentration of endogenous growth hormone in the bloodstream of economic mammals. This is achieved through the simultaneous administration of an estrogen and a growth hormone releasing factor. Another significant invention describes a method for increasing the feed intake of pigs, chickens, or dairy cattle, which have elevated levels of growth hormone, by administering a thyroid-active substance.

Career Highlights

Jack F Wagner is associated with Eli Lilly and Company, where he has been instrumental in developing groundbreaking treatments. His work has had a profound impact on the agricultural sector, particularly in improving livestock health and productivity.

Collaborations

Wagner has collaborated with notable colleagues such as James L Hudson and David B Anderson, contributing to a rich environment of innovation and research.

Conclusion

Jack F Wagner's contributions to the field of growth hormone treatments exemplify the importance of innovation in improving animal health and productivity. His patents reflect a commitment to advancing veterinary medicine and enhancing agricultural practices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…